Premier Alternatives

Biostate AI

Houston, TX · Founded 2023 · Privately Held (backing)

Developer of a biotechnology data aggregation and analysis platform intended for analyzing biopharmaceutical developments. Biostate AI is based in Houston, TX and was founded in 2023. It was valued at $65 million at its early-stage round in May 2025, the last priced event on record. It has raised $16.7 million across 1 recorded round; the latest was a $4.2 million seed round in Apr 2025.

PMV mark · valuation
$65.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$16.7M
Last round
Seed Round
Apr 2025

Biostate AI key facts

as of Oct 2026
  • Developer of a biotechnology data aggregation and analysis platform intended for analyzing biopharmaceutical developments.
  • Biostate AI is valued at approximately $65.0M as of Oct 2026, set at its early-stage round, May 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $16.7M across 1 recorded rounds; the latest was Seed Round ($4.2M) in Apr 2025.
  • Notable investors include Mana Ventures, Accel, Gaingels, InfoEdge Ventures, Vision Plus Capital — 23 tracked in total.
  • Biostate AI has filed 1 Form D with the SEC, most recently May 2025 ($4.2M sold to 7 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$65.0M

Valued at $65.0M at its early-stage round, May 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Biostate AI with a free account
  • ·The complete investor list: 23 names
  • ·Watch Biostate AI: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Biostate AI funding rounds

1 rounds
Apr 2025Seed Round$4.2MSEC filing▮
Full funding history →

Biostate AI valuation

Biostate AI was valued at $65 million at its early-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Biostate AI raised?

Biostate AI has raised $16.7 million in total; 1 of its rounds is on record. The largest on record was a $4.2 million seed round in Apr 2025.

Biostate AI has filed 1 Form D with the SEC, most recently in May 2025 ($4.2 million sold to 7 investors).

Biostate AI investors

23 investors are on record for Biostate AI, including Mana Ventures, Accel, Gaingels and InfoEdge Ventures. By type, the record holds 7 venture capital firms and 1 hedge fund. The seed round in Apr 2025 drew 7 investors.

About Biostate AI

Developer of a biotechnology data aggregation and analysis platform intended for analyzing biopharmaceutical developments. The company's platform integrates diverse data sources, including clinical trial results, regulatory information, and scientific publications, offering tools for data visualization, trend analysis, and predictive insights, enabling researchers to assess drug development progress and make evidence-based decisions.

Sector
Healthcare
HQ
Houston, TX, United States
Founded
2023
Employees
20
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.